MedTrace Logo

Oxytocin Bolus Versus Infusion in Elective Cesarean Section"

NCT05236985 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-03-15

No results posted yet for this study

Summary

Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.

Conditions

  • Elective Cesarean Section

Interventions

DRUG

Oxytocin bolus or oxytocin infusion

On the day of surgery, the patients will be randomized to either bolus or infusion administration of oxytocin. On the day of the procedure, periprocedural data and patient satisfaction (single question) will be recorded.

Sponsors & Collaborators

Principal Investigators

  • Tiffany E Angelo, DO · Stony Brook University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-15
Primary Completion
2024-12-15
Completion
2024-12-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05236985 on ClinicalTrials.gov